Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China - Rong Cheng Li, Feng Xiang Li, Yan Ping Li, Qi Ming Hou, Chang Gui Li, Ya Nan Li, Fu Sheng Chen, Xue Zhong Hu, Wen Bin Su, Shu Min Zhang, Han Hua Fang, Qiang Ye, Tian De Zeng, Tao Xuan Liu, Xiu Bi Li - Dissemin

Language
Login

Published in

Elsevier, Vaccine, 50(29), p. 9337-9344, 2011

DOI: 10.1016/j.vaccine.2011.09.131

Links

Elsevier

Tools

Export citation

Search in Google Scholar

Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China

Journal article published in 2011 by Rong Cheng Li, Feng Xiang Li, Yan Ping Li, Qi Ming Hou, Chang Gui Li, Ya Nan Li, Fu Sheng Chen, Xue Zhong Hu, Wen Bin Su, Shu Min Zhang, Han Hua Fang, Qiang Ye, Tian De Zeng, Tao Xuan Liu, Xiu Bi Li and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO